Barrow, Hanley, Mewhinney & Strauss
AMGN icon

Barrow, Hanley, Mewhinney & Strauss’s Amgen AMGN Stock Holding History

Barrow, Hanley, Mewhinney & Strauss’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1,043
Closed -$192K – 400
2018
Q2 		$192K Sell
1,043
-193
-16% -$34.1K ﹤0.01% 331
2018
Q1 		$210K Buy
1,236
+589
+91% +$108K ﹤0.01% 332
2017
Q4 		$113K Buy
647
+340
+111% +$60.2K ﹤0.01% 331
2017
Q3 		$57K Buy
307
+60
+24% +$10.6K ﹤0.01% 357
2017
Q2 		$43K Sell
247
-1
-0.4% -$163 ﹤0.01% 367
2017
Q1 		$41K Buy
+248
New +$41.2K ﹤0.01% 365

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss's AMGN Position: Q3 2018 in Review

Barrow, Hanley, Mewhinney & Strauss sold out of Amgen (AMGN) in Q3 2018, closing a stake of 1,043 shares — an estimated $192K sold.

Barrow, Hanley, Mewhinney & Strauss first reported a position in AMGN in Q1 2017 and held it in 6 quarters. The position peaked at $210K in Q1 2018. 1,796 funds tracked by Wall St. Rank hold AMGN as of Q3 2018.

  • Barrow, Hanley, Mewhinney & Strauss reported no remaining Amgen position as of Q3 2018 after selling out during the quarter.
  • Barrow, Hanley, Mewhinney & Strauss sold 1,043 Amgen shares in Q3 2018, an estimated $192K.
  • Barrow, Hanley, Mewhinney & Strauss first reported a position in Amgen in Q1 2017 and held it in 6 quarters.
  • Barrow, Hanley, Mewhinney & Strauss's Amgen position peaked at $210K in Q1 2018.
  • 1,796 funds tracked by Wall St. Rank held Amgen as of Q3 2018.

Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q3 2018, filed 13 Nov 2018.